These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24703112)

  • 1. Re: Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN project).
    Laguna MP
    J Urol; 2014 Apr; 191(4):949. PubMed ID: 24703112
    [No Abstract]   [Full Text] [Related]  

  • 2. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN project).
    Taneja SS
    J Urol; 2013 Jan; 189(1):67-8. PubMed ID: 23235204
    [No Abstract]   [Full Text] [Related]  

  • 4. Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma--results from a comprehensive multi-centre database (CORONA/SATURN-Project).
    Brookman-May SD; May M; Shariat SF; Novara G; Zigeuner R; Cindolo L; De Cobelli O; De Nunzio C; Pahernik S; Wirth MP; Longo N; Simonato A; Serni S; Siracusano S; Volpe A; Morgia G; Bertini R; Dalpiaz O; Stief C; Ficarra V; ; ;
    BJU Int; 2013 Nov; 112(7):909-16. PubMed ID: 23890378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephron-sparing surgery for renal cell carcinoma in the solitary kidney.
    Berdjis N; Hakenberg OW; Novotny V; Manseck A; Oehlschläger S; Wirth MP
    Scand J Urol Nephrol; 2007; 41(1):10-3. PubMed ID: 17366096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of small solitary unilateral renal cell carcinomas: impact of central versus peripheral tumor location.
    Hafez KS; Novick AC; Butler BP
    J Urol; 1998 Apr; 159(4):1156-60. PubMed ID: 9507821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.
    Lerner SE; Hawkins CA; Blute ML; Grabner A; Wollan PC; Eickholt JT; Zincke H
    J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of renal-sparing surgery for renal cell carcinoma.
    Novick AC
    Semin Urol; 1992 Feb; 10(1):12-5. PubMed ID: 1565898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma.
    Krambeck AE; Leibovich BC; Lohse CM; Kwon ED; Zincke H; Blute ML
    J Urol; 2006 Nov; 176(5):1990-5; discussion 1995. PubMed ID: 17070231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors for ipsilateral recurrence after nephron-sparing surgery in renal cell carcinoma.
    Bernhard JC; Pantuck AJ; Wallerand H; Crepel M; Ferrière JM; Bellec L; Maurice-Tison S; Robert G; Albouy B; Pasticier G; Soulie M; Lopes D; Lacroix B; Bensalah K; Pfister C; Thuret R; Tostain J; De La Taille A; Salomon L; Abbou C; Colombel M; Belldegrun AS; Patard JJ
    Eur Urol; 2010 Jun; 57(6):1080-6. PubMed ID: 20188458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The indications for partial nephrectomy in the treatment of renal cell carcinoma.
    Joniau S; Vander Eeckt K; Van Poppel H
    Nat Clin Pract Urol; 2006 Apr; 3(4):198-205. PubMed ID: 16607368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale for total nephrectomy for suspected renal cell carcinoma.
    Marsh CL; Lange PH
    Semin Urol Oncol; 1995 Nov; 13(4):273-80. PubMed ID: 8595551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephron-sparing surgery--strategies for partial nephrectomy in renal cell carcinoma.
    Ljungberg B
    Scand J Surg; 2004; 93(2):126-31. PubMed ID: 15285564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney autotransplantation after nephrectomy and work bench surgery as an ultimate approach to nephron-sparing surgery.
    Janssen MWW; Linxweiler J; Philipps I; Bütow Z; Siemer S; Stöckle M; Ohlmann CH
    World J Surg Oncol; 2018 Feb; 16(1):35. PubMed ID: 29463251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cell carcinoma: evaluation of the 1997 TNM system and recommendations for follow-up after surgery.
    Gofrit ON; Shapiro A; Kovalski N; Landau EH; Shenfeld OZ; Pode D
    Eur Urol; 2001 Jun; 39(6):669-74; discussion 675. PubMed ID: 11464056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The local recurrence of renal-cell carcinoma after nephron-sparing surgery].
    Iliukhin IuA; Shchukin DV
    Voen Med Zh; 2005 Feb; 326(2):32-7, 80. PubMed ID: 15822775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elective nephron sparing surgery for renal cell carcinoma larger than 4 cm.
    Pahernik S; Roos F; Röhrig B; Wiesner C; Thüroff JW
    J Urol; 2008 Jan; 179(1):71-4; discussion 74. PubMed ID: 17997423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma.
    Larcher A; Capitanio U; Terrone C; Volpe A; De Angelis P; Dehó F; Fossati N; Dell'Oglio P; Antonelli A; Furlan M; Simeone C; Serni S; Carini M; Minervini A; Fiori C; Porpiglia F; Briganti A; Montorsi F; Bertini R
    J Urol; 2016 Oct; 196(4):1008-13. PubMed ID: 27235789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive surgical margins after nephron-sparing surgery for renal cell carcinoma: incidence, clinical impact, and management.
    Borghesi M; Brunocilla E; Schiavina R; Martorana G
    Clin Genitourin Cancer; 2013 Mar; 11(1):5-9. PubMed ID: 23083800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Conservative surgery in cancer of the kidney].
    Ferrière JM; Pariente JL; Le Guillou M
    Presse Med; 1995 Oct; 24(32):1507-8. PubMed ID: 8545354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.